JP2005532803A5 - - Google Patents

Download PDF

Info

Publication number
JP2005532803A5
JP2005532803A5 JP2004520603A JP2004520603A JP2005532803A5 JP 2005532803 A5 JP2005532803 A5 JP 2005532803A5 JP 2004520603 A JP2004520603 A JP 2004520603A JP 2004520603 A JP2004520603 A JP 2004520603A JP 2005532803 A5 JP2005532803 A5 JP 2005532803A5
Authority
JP
Japan
Prior art keywords
cell
cells
inducing
medium
graft
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004520603A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005532803A (ja
Filing date
Publication date
Priority claimed from DE10231655A external-priority patent/DE10231655A1/de
Application filed filed Critical
Publication of JP2005532803A publication Critical patent/JP2005532803A/ja
Publication of JP2005532803A5 publication Critical patent/JP2005532803A5/ja
Pending legal-status Critical Current

Links

JP2004520603A 2002-07-12 2003-07-11 単球由来の移植片受容誘導細胞ならびにその調製およびその使用 Pending JP2005532803A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10231655A DE10231655A1 (de) 2002-07-12 2002-07-12 Transplantat-Akzeptanz induzierende Zellen monozytären Ursprungs, sowie deren Herstellung und Verwendung
PCT/EP2003/007551 WO2004007701A1 (en) 2002-07-12 2003-07-11 Transplant acceptance inducing cells of monocytic origin and their preparation and use

Publications (2)

Publication Number Publication Date
JP2005532803A JP2005532803A (ja) 2005-11-04
JP2005532803A5 true JP2005532803A5 (https=) 2006-09-21

Family

ID=30009939

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004520603A Pending JP2005532803A (ja) 2002-07-12 2003-07-11 単球由来の移植片受容誘導細胞ならびにその調製およびその使用

Country Status (18)

Country Link
US (1) US20060286670A1 (https=)
EP (2) EP1492869B9 (https=)
JP (1) JP2005532803A (https=)
CN (1) CN100523176C (https=)
AT (2) ATE309331T1 (https=)
AU (1) AU2003250939B2 (https=)
BR (1) BR0312693A (https=)
CA (1) CA2492383A1 (https=)
DE (3) DE10231655A1 (https=)
DK (2) DK1557462T3 (https=)
ES (3) ES2304647T3 (https=)
IL (3) IL166021A0 (https=)
NO (1) NO20050719L (https=)
PT (2) PT1557462E (https=)
RU (1) RU2370535C2 (https=)
SI (3) SI1557462T1 (https=)
WO (1) WO2004007701A1 (https=)
ZA (2) ZA200501054B (https=)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10362002B4 (de) 2003-06-23 2006-10-12 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Adulte pluripotente Stammzellen
KR20060040671A (ko) * 2003-07-11 2006-05-10 블라스티콘 바이오테크놀로지셰 포르슝 게엠베하 단구성 기원의 자기 유래 자가 관용성 유도 세포 및약제학적 제제에 있어서의 이의 용도
EP1928479B1 (en) * 2005-08-24 2016-06-08 Yeda Research And Development Co., Ltd. Universal donor-derived tolerogenic cells for inducing non-syngeneic transplantation tolerance
RU2446826C2 (ru) 2005-10-14 2012-04-10 Фукуока Юниверсити Агенты для подавления повреждения трансплантированных островков после трансплантации островков
AR058135A1 (es) 2005-10-21 2008-01-23 Chugai Pharmaceutical Co Ltd Agentes para el tratamiento de cardiopatias
AR057582A1 (es) 2005-11-15 2007-12-05 Nat Hospital Organization Agentes para suprimir la induccion de linfocitos t citotoxicos
EP2025346B1 (en) 2006-04-07 2016-08-10 Osaka University Muscle regeneration promoter
WO2008090901A1 (ja) * 2007-01-23 2008-07-31 Shinshu University 慢性拒絶反応抑制剤
TWI528973B (zh) 2008-06-05 2016-04-11 Chugai Pharmaceutical Co Ltd Nerve infiltration inhibitor
EP2365823B1 (en) * 2008-10-30 2016-11-30 Yeda Research And Development Company Ltd. Anti third party central memory t cells, methods of producing same and use of same in transplantation and disease treatment
JP5436905B2 (ja) * 2009-03-26 2014-03-05 テルモ株式会社 シート状細胞培養物の製造方法
JP5667357B2 (ja) * 2009-11-30 2015-02-12 テルモ株式会社 シート状細胞培養物の製造方法
CN101812428A (zh) * 2010-04-26 2010-08-25 西北农林科技大学 一种乳腺上皮细胞的组织块种植方法
JP6051049B2 (ja) 2010-05-28 2016-12-21 中外製薬株式会社 抗腫瘍t細胞応答増強剤
DE102011004335A1 (de) 2011-02-17 2012-08-23 Thomas Grammel Verfahren zur Herstellung eines Vakzins
RU2508924C1 (ru) * 2013-02-21 2014-03-10 Государственное бюджетное учреждение здравоохранения Московской области "Московский областной научно-исследовательский клинический институт им. М.Ф. Владимирского" Способ профилактики и лечения отторжения почечного трансплантата
JP5727665B2 (ja) * 2014-12-11 2015-06-03 テルモ株式会社 シート状細胞培養物の製造方法
JP5893786B2 (ja) * 2015-04-02 2016-03-23 テルモ株式会社 シート状細胞培養物の製造方法
KR102769850B1 (ko) * 2015-07-03 2025-02-20 인스티튜트 내셔날 드 라 싼테 에 드 라 리셰르셰 메디칼르 조절 t 세포를 수득하는 방법 및 이의 용도
JP6903866B2 (ja) * 2016-01-27 2021-07-14 国立大学法人 熊本大学 血液由来単球の増殖誘導方法
JP6140322B2 (ja) * 2016-02-24 2017-05-31 テルモ株式会社 シート状細胞培養物の製造方法
JP6490738B2 (ja) * 2017-04-28 2019-03-27 テルモ株式会社 シート状細胞培養物の製造方法
EP3620531A4 (en) 2017-05-02 2021-03-17 National Center of Neurology and Psychiatry METHOD OF PREDICTION AND EVALUATION OF THERAPEUTIC EFFECT IN DISEASES RELATING TO IL-6 AND NEUTROPHILS
EP3698808B1 (en) 2017-10-20 2025-01-01 Hyogo College Of Medicine Anti-il-6 receptor antibody-containing medicinal composition for preventing post-surgical adhesion
WO2019151418A1 (ja) 2018-01-31 2019-08-08 元一 加藤 Il-6阻害剤を含有する喘息の治療剤
JP6657452B2 (ja) * 2019-02-27 2020-03-04 テルモ株式会社 シート状細胞培養物の製造方法
IL287220B2 (en) 2019-04-17 2026-03-01 Univ Hiroshima A therapeutic agent for urological cancer characterized by administering an IL-6 inhibitor in combination with a CCR2 inhibitor
JP7002497B2 (ja) * 2019-06-20 2022-01-20 テルモ株式会社 シート状細胞培養物の製造方法
JP6872051B2 (ja) * 2020-02-05 2021-05-19 テルモ株式会社 シート状細胞培養物の製造方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5766920A (en) * 1982-08-11 1998-06-16 Cellcor, Inc. Ex vivo activation of immune cells
US5683693A (en) * 1994-04-25 1997-11-04 Trustees Of Dartmouth College Method for inducing T cell unresponsiveness to a tissue or organ graft with anti-CD40 ligand antibody or soluble CD40
US9068164B1 (en) * 1995-02-02 2015-06-30 Tristem Trading (Cyprus) Limited Method of preparing an undifferentiated cell
US7410773B2 (en) * 1995-02-02 2008-08-12 Ghazi Jaswinder Dhoot Method of preparing an undifferentiated cell
US7112440B2 (en) * 1995-02-02 2006-09-26 Ghazi Jaswinder Dhoot Method of increasing the relative number of CD45 low cells in a cell population
GB9502022D0 (en) * 1995-02-02 1995-03-22 Abuljadayel Ilham M S A method for preparing lymphohaematopoietic progenitor cells
JP3926842B2 (ja) * 1995-03-08 2007-06-06 ザ・スクリプス・リサーチ・インステイチユート 抗原提示系およびt−細胞の活性化方法
WO1998053048A1 (en) * 1997-05-21 1998-11-26 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Methods and compositions for making dendritic cells from expanded populations of monocytes and for activating t cells
NL1017973C2 (nl) * 2000-05-10 2002-11-08 Tristem Trading Cyprus Ltd Inrichting.
DE60108661T2 (de) * 2000-11-14 2006-01-05 Université Libre de Bruxelles Herstellung und verwendung von dendritischen zellen
TWI288779B (en) * 2002-03-28 2007-10-21 Blasticon Biotech Forschung Dedifferentiated, programmable stem cells of monocytic origin, and their production and use

Similar Documents

Publication Publication Date Title
JP2005532803A5 (https=)
RU2005103627A (ru) Индуцирующие воспринимаемость трансплантата клетки моноцитарного происхождения, их получение и применение
US20230399615A1 (en) Icos critically regulates the expansion and function of inflammatory human th17 cells
Lombardi et al. CD8α+ β− and CD8α+ β+ plasmacytoid dendritic cells induce Foxp3+ regulatory T cells and prevent the induction of airway hyper-reactivity
JP2023052777A5 (https=)
CN107109364A (zh) 缺氧与常氧交替条件下的骨髓浸润淋巴细胞的激活
CA2448599A1 (en) Maturation of antigen-presenting cells using activated t cells
Velardi et al. Lymphokine production by T-cell clones after human bone marrow transplantation
CN113943704B (zh) 一种肿瘤新生抗原特异性t细胞的制备方法
Vandekerckhove et al. Clonal analysis of the peripheral T cell compartment of the SCID-hu mouse
US20040197903A1 (en) Method for induction of proliferation of natural killer cells by dendritic cells cultured with GM-CSF and IL-15
US20210087530A1 (en) Compositions and methods for culturing and expanding cells
JP2003511064A (ja) ヒト末梢血単核細胞由来の樹状細胞の産生および特徴付け
Pancholi et al. Dendritic cells efficiently immunoselect mycobacterial-reactive T cells in human blood, including clonable antigen-reactive precursors
Kalinski et al. Generation of stable Th1/CTL-, Th2-, and Th17-inducing human dendritic cells
JP2648318B2 (ja) ヒトモノクローナル抗体製造法、およびそのキット
JPH11506902A (ja) イン・ビトロtリンパ球生成系
EP1644484B1 (en) Autologous self-tolerance inducing cells of monocytic origin and their use in pharmaceutical proparations
ES2472452B1 (es) Procedimiento para la selección de linfocitos T antígeno-específicos mediante la identificación de dobletes.
Mingari et al. Lymphokine production by T-cell clones after human bone marrow
CN118222483A (zh) 免疫类器官的培养方法及应用
Baum The Role of Interleukin-21 in the Chronic Rejection of Transplant Allografts and the Development of Type 1 Diabetes
CZ20160U1 (cs) Individuální imunoterapeutická protinádorová vakcína
Carter et al. Sam Schatten, Jeffrey A. Drebin, Muneo Takaoki
Ajduk et al. Detection of regulatory T cells in human blood